Today's pre-market stock movers: BBIO, LZB, ORA, DOW and more

• $La-Z-Boy (LZB.US)$ +9.3% (In reaction to earnings/guidance)

• $Enanta Pharmaceuticals (ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer (PFE.US)$ )

• $Ikena Oncology (IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)

• $BridgeBio Pharma (BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)

• $Krystal Biotech (KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-VEC)

• $ANI Pharmaceuticals (ANIP.US)$ +4.2% (announces FDA approval and imminent launch of clorazepate dipotassium tablets USP)

• $Avnet (AVT.US)$ +3.2% (forms strategic collaboration with Amazon Web Services)

• $Safe Bulkers (SB.US)$ +2.9% (authorizes new 5 mln share repurchase program)

• $Matthews International (MATW.US)$ +1.3% (to acquire German-based engineering firms OLBRICH and R+S Automotive for approximately $45 mln)

• $Fluor (FLR.US)$ +1.2% (awarded a contract to perform engineering procurement and construction management for Iluka Resources Limited's Eneabba project)

• $Paratek Pharmaceuticals (PRTK.US)$ +1.1% (Nuzyra receives FDA Fast Track Designation)

• $NatWest (NWG.US)$ +3.8% (upgraded to Buy from Hold at Jefferies)

• $Enerpac Tool (EPAC.US)$ +2.3% (upgraded to Overweight from Equal Weight at Wells Fargo)

• $Taylor Morrison Home (TMHC.US)$ +2.1% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)

• $Summit Materials (SUM.US)$ +1.8% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)

• $The Kraft Heinz (KHC.US)$ +1.4% (upgraded to Outperform from Market Perform at BMO Capital Markets)

• $Brixmor Property Group Inc (BRX.US)$ +1.1% (upgraded to Overweight from Neutral at JP Morgan)

• $Winnebago Industries (WGO.US)$ +2.6% (In reaction to earnings/guidance)

• $Korn Ferry (KFY.US)$ +2% (In reaction to earnings/guidance)

• $Sonoco Products (SON.US)$ +0.8% (guidance)

• $Athira (ATHA.US)$ -67.2% (topline results from ACT-AD Phase 2 proof of concept study of fosgonimeton in Alzheimer's disease; Primary endpoint of change in biomarker ERP P300 latency was not statistically significant)

• $Micro Focus International (MFGP.US)$ -17.9% (In reaction to earnings/guidance)

• $BigBear.ai Holdings (BBAI.US)$ -5.6% (stock offering)

• $Ormat Technologies (ORA.US)$ -3.5% ($350mln convertible notes offering)

• $Paya Holdings (PAYA.US)$ -3.2% (selected by Promise as an integrated payments partner)

• $Delek US (DK.US)$ -2.7% (declares a special dividend of $0.20/sh)

• $Galapagos (GLPG.US)$ -2.2% (to acquire Cell Point and Abound Bio for 125mln and $14mln, respectively)

• $High Tide (HITI.US)$ -1.9% (to proceed with a small debt facility at this time as the proposed non-dilutive credit facilities for CAD $30mln (as previously announced on April18, 2022) has been delayed until July 2022)

• $ProFrac Holding (PFHC.US)$ -1.3% (acquires U.S. Well Services)

• $Enviva (EVA.US)$ -0.8% (reaffirms FY22 guidance)

• $ArcelorMittal SA (MT.US)$ -6.7% (downgraded to NeutralfromOverweight atJPMorgan)

• $Dow Inc (DOW.US)$ -4.6% (downgraded to Underperform from Neutral at Credit Suisse)

• $Airbnb (ABNB.US)$ -2.8% (downgraded to MktPerform from MktOutperform at JMP Securities)

• $The Scotts Miracle (SMG.US)$ -2.8% (downgraded to Equal Weightfrom Overweight at Wells Fargo)

• $Burlington Stores (BURL.US)$ -2.6% (downgraded to Market Perform from Outperform at Cowen)

• $PulteGroup (PHM.US)$ -2.5% (downgraded to Sector Performfrom Outperformat RBC Capital Mkts)

• $Nike (NKE.US)$ -2.2% (downgraded to Neutral from Buyat Seaport Research Partners)

• $Boston Beer (SAM.US)$ -2.1% (downgraded to Mkt Performfrom Outperformat Bernstein)

• $Anthem (ANTM.US)$ -1.8% (downgraded to Equal-Weight from Overweight at Morgan Stanley)